Complaint — No. 6:24-cv-06358 (Dkt. 1, W.D.N.Y.)

Summary

A qui tam complaint under the False Claims Act filed under seal by relator GNGH2 Inc. on behalf of the United States against Immco Diagnostics Inc. and Primus Corporation, Case No. 6:24-cv-06358-FPG, in the U.S. District Court for the Western District of New York, filed June 10, 2024 as Document 1. The complaint alleges the defendants, subsidiaries of Trinity Biotech that make and sell diagnostic test kits, falsely certified they met size standards when they received second draw PPP loans of $1,042,255 (2/27/21) and $721,530 (1/30/21). It asserts a claim under 31 U.S.C. Section 3729(a)(1)(B) and states the United States paid totals of $1,079,205.08 and $747,327.17 including processing fees. It seeks judgments of $3,237,615.24 against Immco and $2,241,981.51 against Primus, and is filed by relator's counsel David Abrams.

Summary drafted by a model from the text of the original file linked on this page and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used